{"transactions":[{"id":1844868,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T21:24:28.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 22, 2024 or the day immediately prior to the company's 2024 annual meeting of shareholders."}],"balance_after":35000,"derivative":{"exercise_price":5.46,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000899243-23-016398","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000089924323016398/doc4.xml","form_type":"4"}},{"id":2221780,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T20:31:17.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 22, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders."}],"balance_after":35000,"derivative":{"exercise_price":3.22,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000899243-22-023979","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000089924322023979/doc4.xml","form_type":"4"}},{"id":2659996,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-21T20:30:34.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 16, 2022 or the day immediately prior to the company's 2022 annual meeting of shareholders."}],"balance_after":23000,"derivative":{"exercise_price":19.74,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0000899243-21-024994","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000089924321024994/doc4.xml","form_type":"4"}},{"id":2698184,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-24T17:16:26.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become fully exercisable on the earlier of the first anniversary following the date of grant or the next scheduled Annual Meeting."}],"balance_after":20000,"derivative":{"exercise_price":3.24,"expiration_date":"2031-05-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-21-071340","document":"tm2116997-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633070/000110465921071340/tm2116997-4_4seq1.xml","form_type":"4"}},{"id":3006775,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-14T16:15:28.000Z","date":"2020-10-13","kind":"disposition_to_issuer","acquired":false,"shares":15398,"price":17.39,"value":267771.22,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."}],"balance_after":0,"derivative":{"exercise_price":17.11,"underlying":"Common Stock","underlying_shares":15398},"source":{"system":"sec-edgar","filing":"0000899243-20-028179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924320028179/doc4.xml","form_type":"4"}},{"id":3006774,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-14T16:15:28.000Z","date":"2020-10-13","kind":"disposition_to_issuer","acquired":false,"shares":11432,"price":14.6,"value":166907.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."}],"balance_after":0,"derivative":{"exercise_price":19.9,"underlying":"Common Stock","underlying_shares":11432},"source":{"system":"sec-edgar","filing":"0000899243-20-028179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924320028179/doc4.xml","form_type":"4"}},{"id":3006773,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-14T16:15:28.000Z","date":"2020-10-13","kind":"disposition_to_issuer","acquired":false,"shares":7500,"price":1.71,"value":12825.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."}],"balance_after":0,"derivative":{"exercise_price":32.79,"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000899243-20-028179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924320028179/doc4.xml","form_type":"4"}},{"id":3006772,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-14T16:15:28.000Z","date":"2020-10-13","kind":"disposition_to_issuer","acquired":false,"shares":17500,"price":16.24,"value":284200.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."}],"balance_after":0,"derivative":{"exercise_price":18.26,"underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000899243-20-028179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924320028179/doc4.xml","form_type":"4"}},{"id":3006771,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-14T16:15:28.000Z","date":"2020-10-13","kind":"disposition_to_issuer","acquired":false,"shares":39510,"price":9.6,"value":379296.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each stock option outstanding and unexercised immediately prior to the Effective Time vested in full, terminated and was converted into the right to receive a cash payment equal to the product of (i) the number of shares of common stock that were subject to such stock option immediately prior to the Effective Time and (ii) the excess, if any, of the Offer Price over the per share exercise price of such stock option."}],"balance_after":0,"derivative":{"exercise_price":24.9,"underlying":"Common Stock","underlying_shares":39510},"source":{"system":"sec-edgar","filing":"0000899243-20-028179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924320028179/doc4.xml","form_type":"4"}},{"id":3006770,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-10-14T16:15:28.000Z","date":"2020-10-13","kind":"disposition_to_issuer","acquired":false,"shares":7840,"price":34.5,"value":270480.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to the Merger Agreement, each Issuer restricted stock unit (\"RSU\") that was outstanding immediately prior to the date and time at which the Merger became effective (the \"Effective Time\") vested in full, terminated, and was converted into the right to receive a cash payment equal to (i) $34.50 per share (the \"Offer Price\") multiplied by (ii) the number of shares of common stock subject to the RSU."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-028179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924320028179/doc4.xml","form_type":"4"}},{"id":3006769,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-10-14T16:15:28.000Z","date":"2020-10-13","kind":"other","acquired":false,"shares":10192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated August 29, 2020, by and between the Issuer, Societes des Produits Nestle S.A., and SPN MergerSub, Inc (the \"Merger Agreement\"), the securities were cancelled and will cease to exist, and no consideration was delivered in exchange for such cancellation."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-028179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924320028179/doc4.xml","form_type":"4"}},{"id":3102747,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-22T20:09:04.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 18, 2021 or the day immediately prior to the company's 2021 annual meeting of shareholders."}],"balance_after":30000,"derivative":{"exercise_price":4.4,"expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-20-017347","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000089924320017347/doc4.xml","form_type":"4"}},{"id":3130105,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-29T19:17:41.000Z","date":"2020-05-27","kind":"grant","acquired":true,"shares":15398,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2021 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":15398,"derivative":{"exercise_price":17.11,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":15398},"source":{"system":"sec-edgar","filing":"0000899243-20-014619","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924320014619/doc4.xml","form_type":"4"}},{"id":3130104,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-05-29T19:17:41.000Z","date":"2020-05-27","kind":"grant","acquired":true,"shares":7840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") and will be settled in common stock upon vesting.  The RSUs vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2021 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":18032,"source":{"system":"sec-edgar","filing":"0000899243-20-014619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924320014619/doc4.xml","form_type":"4"}},{"id":3136455,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-22T17:16:22.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become fully exercisable on the earlier of the first anniversary following the date of grant or the next scheduled Annual Meeting."}],"balance_after":11000,"derivative":{"exercise_price":4.2,"expiration_date":"2030-05-19","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001104659-20-065466","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633070/000110465920065466/a4.xml","form_type":"4"}},{"id":3489037,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-14T20:12:05.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 13, 2020 or the day immediately prior to the company's 2020 annual meeting of shareholders."}],"balance_after":15000,"derivative":{"exercise_price":2.83,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-19-017018","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000089924319017018/doc4.xml","form_type":"4"}},{"id":3509907,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-28T21:22:48.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":11432,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2020 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":11432,"derivative":{"exercise_price":19.9,"expiration_date":"2029-05-23","underlying":"Common Stock","underlying_shares":11432},"source":{"system":"sec-edgar","filing":"0000899243-19-014971","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924319014971/doc4.xml","form_type":"4"}},{"id":3509906,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-05-28T21:22:48.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":6442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") and will be settled in common stock upon vesting.  The RSUs vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2020 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":10192,"source":{"system":"sec-edgar","filing":"0000899243-19-014971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924319014971/doc4.xml","form_type":"4"}},{"id":3511338,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-24T16:05:00.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become fully exercisable on the earlier of the first anniversary following the date of grant or the next scheduled Annual Meeting."}],"balance_after":11000,"derivative":{"exercise_price":14.28,"expiration_date":"2029-05-21","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001104659-19-031783","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633070/000110465919031783/a4.xml","form_type":"4"}},{"id":3881978,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-28T01:02:58.000Z","date":"2018-06-26","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 26, 2019 or the day immediately prior to the company's 2019 annual meeting of shareholders."}],"balance_after":15000,"derivative":{"exercise_price":9.09,"expiration_date":"2027-06-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-18-018513","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000089924318018513/doc4.xml","form_type":"4"}},{"id":3918197,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-24T17:08:55.000Z","date":"2018-05-23","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2019 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":7500,"derivative":{"exercise_price":32.79,"expiration_date":"2028-05-23","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000899243-18-013930","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924318013930/doc4.xml","form_type":"4"}},{"id":3918196,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-05-24T17:08:55.000Z","date":"2018-05-23","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") and will be settled in common stock upon vesting.  The RSUs vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2019 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":3750,"source":{"system":"sec-edgar","filing":"0000899243-18-013930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924318013930/doc4.xml","form_type":"4"}},{"id":4275060,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-21T21:09:18.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 20, 2018 or the day immediately prior to the company's 2018 annual meeting of shareholders."}],"balance_after":15000,"derivative":{"exercise_price":11.21,"expiration_date":"2027-06-19","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-17-016854","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000089924317016854/doc4.xml","form_type":"4"}},{"id":4300921,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-30T16:05:25.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2018 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":17500,"derivative":{"exercise_price":18.26,"expiration_date":"2027-05-25","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000899243-17-014688","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924317014688/doc4.xml","form_type":"4"}},{"id":4540815,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":111953,"kind":"person","name":"Behar Gregory","position":1,"cik":"0001643766","reported_name":"Behar Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-11-28T16:05:32.000Z","date":"2016-11-23","kind":"grant","acquired":true,"shares":39510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable with respect to 1/36th of the total number of shares subject to the option in successive, equal monthly installments measured from November 23, 2016, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":39510,"derivative":{"exercise_price":24.9,"expiration_date":"2026-11-22","underlying":"Common Stock","underlying_shares":39510},"source":{"system":"sec-edgar","filing":"0000899243-16-034428","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631650/000089924316034428/doc4.xml","form_type":"4"}}]}